Shareholders Equity (Quarterly) Chart

View Shareholders Equity (Quarterly) for PLUR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shareholders Equity (Quarterly) Chart
Start Trial

Historical Shareholders Equity (Quarterly) Data

View and export this data back to 2004. Start Trial.
Date Value
March 31, 2026 -18.60M
December 31, 2025 -14.61M
September 30, 2025 -11.36M
June 30, 2025 -6.842M
March 31, 2025 -4.474M
December 31, 2024 -8.028M
September 30, 2024 -5.283M
June 30, 2024 0.096M
March 31, 2024 -0.356M
December 31, 2023 4.399M
September 30, 2023 8.901M
June 30, 2023 13.36M
March 31, 2023 19.06M
December 31, 2022 23.19M
September 30, 2022 24.19M
June 30, 2022 30.04M
March 31, 2022 38.09M
December 31, 2021 39.84M
September 30, 2021 48.91M
June 30, 2021 57.15M
March 31, 2021 68.14M
December 31, 2020 41.15M
September 30, 2020 48.95M
June 30, 2020 56.10M
March 31, 2020 14.17M
Date Value
December 31, 2019 15.91M
September 30, 2019 17.53M
June 30, 2019 21.82M
March 31, 2019 8.627M
December 31, 2018 15.19M
September 30, 2018 21.53M
June 30, 2018 28.51M
March 31, 2018 33.23M
December 31, 2017 36.96M
September 30, 2017 24.36M
June 30, 2017 30.25M
March 31, 2017 35.62M
December 31, 2016 25.11M
September 30, 2016 32.90M
June 30, 2016 38.16M
March 31, 2016 43.11M
December 31, 2015 49.35M
September 30, 2015 52.35M
June 30, 2015 58.93M
March 31, 2015 45.84M
December 31, 2014 49.39M
September 30, 2014 53.70M
June 30, 2014 62.12M
March 31, 2014 65.96M
December 31, 2013 60.83M

Shareholders' Equity Definition

Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.

Read full definition.

Shareholders Equity (Quarterly) Range, Past 5 Years

View Shareholders Equity (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shareholders Equity (Quarterly) Benchmarks

View Shareholders Equity (Quarterly) Benchmarks
Start Trial
Compugen Ltd. 88.73M
Evogene Ltd. -3.29M
Scinai Immunotherapeutics Ltd. 11.73M
CollPlant Biotechnologies Ltd. 4.886M
Regentis Biomaterials Ltd. --

Shareholders Equity (Quarterly) Related Metrics